Metabolism of topical drugs within the skin, in particular glucocorticoids.
Kubota
K
K
Department of Dermatology, University of California at San Francisco.
Ademola
J
J
Maibach
H I
HI
D000279:Administration, Cutaneous; D001623:Betamethasone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D001624:Betamethasone Valerate / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001711:Biotransformation; D002478:Cells, Cultured; D046508:Culture Techniques / Q000379:methods; D004353:Drug Evaluation, Preclinical / Q000379:methods; D000078404:Epidermal Cells; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D012867:Skin / Q000378:metabolism*
C085708:betamethasone 21-valerate; D001623:Betamethasone; D001624:Betamethasone Valerate